Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-21 Sale |
2021-05-24 8:12 pm |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
324,869 | $34.75 | $11,290,421 | 4,279,231 (Indirect) |
View |
| 2021-05-20 Sale |
2021-05-21 4:02 pm |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell President and CEO |
3,770 | $35.03 | $132,065 | 138,584 (Indirect Direct) |
View |
| 2021-05-18 Sale |
2021-05-20 7:56 pm |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
46,904 | $34.37 | $1,611,964 | 4,625,934 (Indirect) |
View |
| 2021-05-18 Sale |
2021-05-20 7:21 pm |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
20,667 | $34.37 | $710,270 | 2,582,422 (Indirect) |
View |
| 2021-05-18 Sale |
2021-05-20 6:19 pm |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell President and CEO |
5,600 | $35.04 | $196,228 | 142,354 (Indirect Direct) |
View |
| 2021-05-17 Sale |
2021-05-18 5:53 pm |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
15,000 | $32.71 | $490,710 | 35,533 (Direct) |
View |
| 2021-04-15 Sale |
2021-04-19 5:44 pm |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell President and CEO |
5,512 | $35.01 | $192,975 | 147,954 (Indirect Direct) |
View |
| 2021-03-12 Sale |
2021-03-15 5:11 pm |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
376,412 | $28.18 | $10,607,290 | 2,627,360 (Indirect) |
View |
| 2021-03-12 Sale |
2021-03-15 5:10 pm |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
695,000 | $28.18 | $19,585,100 | 4,697,109 (Indirect) |
View |
| 2020-12-28 Sale |
2020-12-30 5:10 pm |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
34,744 | $33.92 | $1,178,456 | 105,383 (Direct) |
View |
| 2020-12-22 Sale |
2020-12-28 4:40 pm |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
57,979 | $33.46 | $1,939,934 | 429,712 (Direct) |
View |
| 2020-12-21 Sale |
2020-12-22 4:37 pm |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
40,000 | $33.08 | $1,323,200 | 243,183 (Direct) |
View |
| 2020-12-16 Sale |
2020-12-18 8:29 pm |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
17,277 | $34.94 | $603,692 | 204,596 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-05-18 Other |
2021-05-20 7:56 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
21,834 | $0 | 4,625,934 (Indirect) |
View |
| 2021-05-18 Other |
2021-05-20 7:21 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
21,834 | $0 | 2,582,422 (Indirect) |
View |
| 2021-05-13 Option Award |
2021-05-14 4:58 pm |
N/A 2031-05-13 |
Repare Therapeutics Inc. | RPTX | Bonita David P Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-14 4:57 pm |
N/A 2031-05-13 |
Repare Therapeutics Inc. | RPTX | Jerel Davis Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-14 4:56 pm |
N/A 2031-05-13 |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-14 4:55 pm |
N/A 2031-05-13 |
Repare Therapeutics Inc. | RPTX | Kulkarni Samarth Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-14 4:53 pm |
N/A 2031-05-13 |
Repare Therapeutics Inc. | RPTX | Morrison Briggs Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-14 4:52 pm |
N/A 2031-05-13 |
Repare Therapeutics Inc. | RPTX | RHOADS ANN D Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-14 4:51 pm |
N/A 2031-05-13 |
Repare Therapeutics Inc. | RPTX | SCHAFER CAROL Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2021-05-05 Other |
2021-05-07 4:38 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital V L.P. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Ventures V (Canada) L.P. 10% Owner |
341,275 | $0 | 3,397,481 (Indirect) |
View |
| 2021-05-05 Other |
2021-05-07 4:27 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner |
341,275 | $0 | 3,397,481 (Indirect) |
View |
| 2021-05-05 Other |
2021-05-07 4:27 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Jerel Davis Director 10% Owner |
344,117 | $0 | 3,412,071 (Indirect) |
View |
| 2021-03-15 Other |
2021-03-15 5:11 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
24,271 | $0 | 2,627,360 (Indirect) |
View |
| 2021-03-15 Other |
2021-03-15 5:10 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
24,271 | $0 | 4,697,109 (Indirect) |
View |
| 2021-02-16 Other |
2021-02-18 5:13 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner |
362,672 | $0 | 3,243,572 (Indirect) |
View |
| 2021-02-16 Other |
2021-02-18 5:09 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Jerel Davis Director 10% Owner |
363,502 | $0 | 2,795,026 (Indirect) |
View |
| 2021-02-16 Other |
2021-02-18 5:09 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital V L.P. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Ventures V (Canada) L.P. 10% Owner |
362,672 | $0 | 2,785,290 (Indirect) |
View |
| 2021-02-08 Option Award |
2021-02-10 9:07 pm |
N/A 2031-02-08 |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer |
71,000 | $0 | 71,000 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 9:06 pm |
N/A 2031-02-08 |
Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer |
125,000 | $0 | 125,000 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 9:05 pm |
N/A 2031-02-08 |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
125,000 | $0 | 125,000 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 9:04 pm |
N/A 2031-02-08 |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell President and CEO |
125,000 | $0 | 125,000 (Direct) |
View |
| 2021-01-29 Other |
2021-02-02 6:54 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital V L.P. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Ventures V (Canada) L.P. 10% Owner |
736,081 | $0 | 751,218 (Indirect) |
View |
| 2021-01-29 Other |
2021-02-02 6:49 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Jerel Davis Director 10% Owner |
741,358 | $0 | 764,571 (Indirect) |
View |
| 2021-01-29 Other |
2021-02-02 6:43 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner |
736,081 | $0 | 1,259,500 (Indirect) |
View |
| 2021-01-14 Other |
2021-01-19 8:17 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner |
583,680 | $0 | 1,155,090 (Indirect) |
View |
| 2021-01-14 Other |
2021-01-19 8:16 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital V L.P. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Ventures V (Canada) L.P. 10% Owner |
583,680 | $0 | 596,808 (Indirect) |
View |
| 2021-01-14 Other |
2021-01-19 7:40 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Jerel Davis Director 10% Owner |
586,479 | $0 | 602,406 (Indirect) |
View |
| 2020-12-28 Exercise |
2020-12-30 5:10 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
48 | $2.062 | 105,383 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-30 5:10 pm |
N/A 2029-03-29 |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
48 | $0 | 105,383 (Direct) |
View |
| 2020-12-22 Exercise |
2020-12-28 4:40 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
30,809 | $2.062 | 429,712 (Direct) |
View |
| 2020-12-23 Exercise |
2020-12-28 4:40 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
9,488 | $2.425 | 429,712 (Direct) |
View |
| 2020-12-22 Exercise |
2020-12-28 4:40 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
17,682 | $1.637 | 429,712 (Direct) |
View |
| 2020-12-22 Exercise |
2020-12-28 4:40 pm |
N/A 2027-12-04 |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
57,979 | $0 | 429,712 (Direct) |
View |
| 2020-12-21 Exercise |
2020-12-22 4:37 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
40,000 | $2.425 | 243,183 (Direct) |
View |
| 2020-12-21 Exercise |
2020-12-22 4:37 pm |
N/A 2029-12-16 |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
40,000 | $0 | 243,183 (Direct) |
View |
| 2020-12-18 Exercise |
2020-12-18 8:29 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
8,321 | $2.062 | 204,596 (Direct) |
View |
| 2020-12-16 Exercise |
2020-12-18 8:29 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
8,956 | $1.637 | 204,596 (Direct) |
View |
| 2020-12-16 Exercise |
2020-12-18 8:29 pm |
N/A 2027-06-14 |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
17,277 | $0 | 204,596 (Direct) |
View |
| 2020-12-15 Other |
2020-12-17 9:05 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner |
325,000 | $0 | 4,545,416 (Indirect) |
View |
| 2020-12-15 Other |
2020-12-17 9:04 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Jerel Davis Director 10% Owner |
325,000 | $0 | 4,545,416 (Indirect) |
View |
| 2020-12-15 Other |
2020-12-17 9:03 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital V L.P. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Ventures V (Canada) L.P. 10% Owner |
325,000 | $0 | 4,545,416 (Indirect) |
View |
Ownership(A) |
2020-07-06 5:56 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer |
0 | $0 | 193,830 (Direct) |
View |